TOMA Biosciences, Inc. is a Genomics Company

By July 5, 2015Press Releases

Foster City, CA – July 5, 2015 – TOMA Biosciences, Inc. is a genomics company that provides physicians information to optimize treatment for cancer patients. TOMA’s proprietary sequencing solution turns the latest next generation sequencing (NGS) technology into a powerful digital tool to detect the most clinically meaningful changes in a patient’s tumor DNA. Physicians use this important data to optimize treatment for their patients. TOMA is a commercial stage private venture baked company headquartered in Foster City, California.